三尖瓣反流在射血分数保留的心力衰竭全谱系中的表现
本研究纳入1091例患者(中位年龄65岁,60.3%女性),其中669例(61.3%)为HFpEF,比较不同表型(运动/静息HFpEF±肺动脉血管疾病)及心房型/心室型STR的分布与预后。中重度STR总体占17.4%,随PVD加重而增加;V-STR占STR的69%,独立关联死亡或心衰住院复合终点(HR 1.70),A-STR仅关联心衰住院风险增加。
要点
- 中重度STR在HFpEF中占17.4%,且随PVD加重而增加。
- V-STR占STR的69%,独立关联死亡或心衰住院复合终点。
- A-STR仅关联心衰住院风险增加,不关联死亡风险。
核心结论
- HFpEF中的STR与PVD相关,与静息充盈压升高的关联较弱。
- V-STR是HFpEF中更常见的STR表型,但患者也存在显著心房肌病,提示混合机制。
- V-STR带来超额死亡和心衰住院风险,而A-STR仅带来超额心衰住院风险。
研究设计与样本
- 研究纳入1091例患者,中位年龄65岁,60.3%为女性。
- 其中669例(61.3%)为HFpEF,分为运动HFpEF-PVD(20.2%)、静息HFpEF-PVD(38.6%)、运动HFpEF+PVD(15.5%)、静息HFpEF+PVD(25.7%)。
- PVD定义为肺血管阻力>2 WU;充盈压升高分为静息与激发(抬腿或运动)。
- 比较心脏结构、功能、血流动力学和临床结局,并按心房型STR(A-STR)或心室型STR(V-STR)分类。
主要发现
- 中重度STR总体占17.4%,随PVD增加而升高(四组分别为6.7%、11.6%、18.3%、33.7%)。
- 运动-only HFpEF中中重度STR仍比非心源性呼吸困难患者更常见(11.7% vs 6.5%;P=0.047)。
- 69%的STR符合V-STR标准,V-STR患者房颤患病率与A-STR相似,但心房重构更重。
- V-STR独立关联死亡或心衰住院复合终点(多变量HR 1.70;95%CI 1.10-2.65),以及死亡和心衰住院各自单独终点。
- A-STR关联心衰住院风险增加(多变量Fine-Gray HR 2.21;95%CI 1.12-4.37)。
关键数值与推荐
- PVD判定标准:肺血管阻力>2 WU。
- 中重度STR总体患病率17.4%,四组分别为6.7%、11.6%、18.3%、33.7%。
- 运动-only HFpEF vs 非心源性呼吸困难:中重度STR 11.7% vs 6.5%,P=0.047。
- V-STR与死亡或心衰住院复合终点:多变量HR 1.70(95%CI 1.10-2.65)。
- A-STR与心衰住院:多变量Fine-Gray HR 2.21(95%CI 1.12-4.37)。
临床怎么用
- 在HFpEF评估中应关注三尖瓣反流,尤其合并PVD者。
- 区分V-STR与A-STR有助于预后分层,V-STR提示死亡和心衰住院风险更高。
- 运动负荷血流动力学评估有助于识别运动HFpEF中的STR。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Secondary tricuspid regurgitation (STR) in heart failure with preserved ejection fraction (HFpEF) is linked to more advanced stages with pulmonary vascular disease (PVD), but it may also develop at earlier stages of HFpEF, such as those with isolated exercise-induced congestion. OBJECTIVES: This study sought to evaluate the prevalence, distribution, and prognostic significance of STR mechanisms across the spectrum of HFpEF. METHODS: Cardiac structure, function, hemodynamics, and clinical outcomes were compared among patients with HFpEF phenotypes categorized according to the presence of PVD (pulmonary vascular resistance >2 WU), and elevation in filling pressure at rest vs provocation (leg-elevation or exercise), as well as according to the presence of atrial or ventricular STR (A-STR, V-STR). RESULTS: Of 1,091 patients (median age 65 years, 60.3% women), 669 (61.3%) had HFpEF (20.2% exercise HFpEF - PVD, 38.6% rest HFpEF - PVD, 15.5% exercise HFpEF + PVD, 25.7% rest HFpEF + PVD). Moderate or severe STR was present in 17.4% overall, but increased with PVD (6.7%, 11.6%, 18.3%, and 33.7%, respectively), although moderate or severe STR was still more common in exercise-only HFpEF vs noncardiac dyspnea patients (11.7% vs 6.5%; P = 0.047). Most STR (69%) fulfilled criteria for V-STR, but those individuals had similar atrial fibrillation prevalence and greater atrial remodeling compared with A-STR. V-STR was independently associated with composite of death or heart failure (HF) hospitalization (multivariable HR: 1.70; 95% CI: 1.10-2.65) as well as death and HF hospitalizations each alone, whereas A-STR was associated with increased risk of HF hospitalizations (multivariable Fine-Gray HR: 2.21; 95% CI: 1.12-4.37). CONCLUSIONS: STR in HFpEF is associated with PVD and less strongly with higher resting filling pressure. Although V-STR is the more common phenotype of STR in HFpEF, these patients also have substantial atrial myopathy, suggesting a mixed mechanism. TR was more prevalent in exercise HFpEF and exercise pulmonary hypertension than with noncardiac dyspnea; with none in the latter group having moderate-severe or severe TR, highlighting the importance of exercise hemodynamics. V-STR conferred excess mortality and HF hospitalizations, but A-STR conferred only excess HF hospitalizations.
引用
- Naser, Harada, Tada, et al. Tricuspid Regurgitation Across the Spectrum of Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol. 2025. PMID: 41159979. doi:10.1016/j.jacc.2025.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。